Responding to inquiries from the House Budget Committee, the Congressional Budget Office (CBO) has signaled its openness to examining new…
Browsing: Drug Pricing: Policy Activity
A recent report by the Alliance for Patient Access (AfPA) titled “At What Price? Medication Value, Patient Care & the…
A recent report by the Government Accountability Office found that despite the substantial rebates private plans received for Medicare Part…
On September 19, 2023, the Movement Disorders Policy Coalition (MDPC) sent a letter to Chairwoman Friedman and Chairman Lawn of…
On September 11, 2023, Aimed Alliance sent a letter to Centers for Medicare and Medicaid Services (CMS) commenting on CMS’s…
On January 17, 2023, the Institute for Clinical and Economic Review (ICER) published its second annual “Barriers to Fair Access”…
On November 26, 2021, Aimed Alliance sent a letter to U.S. Senators Carper, Coons, Cortez, Masto, Menendez, Murray, Sinema, Schumer and Wyden…
On December 21, 2020, the Centers for Medicare and Medicaid Services (CMS) finalized a rule to alter the method by…
According to a new study in the New England Journal of Medicine (NEJM), three states have helped their residents save…
Today, the House is set to vote on H.R. 1425, “Patient Protection and Affordable Care Enhancement Act.” The bill contains…